UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 24, 2011
AMICUS THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
001-33497
|
|
71-0869350 |
| |
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.) |
| |
|
|
6 Cedar Brook Drive, Cranbury, NJ
|
|
08512 |
| |
|
|
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (609) 662-2000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment
of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) On May 24, 2011, the stockholders of Amicus Therapeutics, Inc. (the “Company”) approved
the Amended and Restated 2007 Equity Incentive Plan (the “Plan”) at the Company’s 2011 Annual
Meeting of Stockholders (the “Annual Meeting”). The amendments to the Plan make an additional
5,000,000 shares of the Company’s common stock available for issuance and increase the maximum
number of shares within the Plan that may be issued as restricted stock, restricted stock units,
stock grants and any other similar awards from 300,000 to 1,146,600 shares.
The foregoing description of the Plan is not complete and is qualified in its entirety by
reference to the Plan filed as Exhibit 10.1 hereto and incorporated herein by reference.
Item 5.07 Submission of Matters to a Vote of Security Holders.
At the Annual Meeting held on May 24, 2011, the Company’s stockholders elected Alexander E.
Barkas, Ph.D. and James Barrett, Ph.D. as Class I directors each to serve a three-year term
expiring at the 2014 Annual Meeting of Stockholders or until their respective successors have
been elected. In addition, the stockholders approved the Plan and ratified the appointment of
Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal
year ending December 31, 2011. The final voting results on these matters were as follows:
| |
|
|
|
|
| Nominee |
|
Votes For |
|
Votes Withheld |
Alexander E. Barkas, Ph.D. |
|
28,104,978 |
|
71,618 |
James Barrett, Ph.D. |
|
28,126,851 |
|
49,745 |
| 2. |
|
Approval of Amended and Restated 2007 Equity Incentive Plan |
| |
|
|
|
|
|
|
| Votes For |
|
Votes Against |
|
Votes Abstain |
|
Broker Non-Votes |
| 26,654,244
|
|
1,518,808
|
|
3,544
|
|
2,517,581 |
| 3. |
|
Ratification of Ernst & Young LLP as the Company’s Independent Registered Public Accounting
Firm for the Fiscal Year Ending December 31, 2011 |
| |
|
|
|
|
| Votes For |
|
Votes Against |
|
Votes Abstain |
| 30,691,634
|
|
25
|
|
2,518 |
Item 9.01. Financial Statements and Exhibits.
|
|
|
| (d) Exhibits: |
|
The Exhibit Index annexed hereto is incorporated herein by reference. |